Skip to main content
. Author manuscript; available in PMC: 2008 Sep 17.
Published in final edited form as: Bioconjug Chem. 2005;16(5):1282–1290. doi: 10.1021/bc050201y

1.

1

Conjugation strategy. The drug-linker vcMMAE reacts with a mAb cysteine to form the ADC. The potent antimitotic agent MMAE is released from the ADC following proteolysis. As many as 8 molecules of vcMMAE can react with each mAb following reduction of the 4 interchain disulfides present in cAC10.